REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Shanghai Medicilon Inc. Profile Updated: January 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Shanghai Medicilon Inc. is mainly engaged in pre-clinical comprehensive research and development services for biomedicine. The company was founded in 2004 and is headquartered in Shanghai, China.

Headquarters
No. 585, Chuanda Road, Chuansha New Town, Pudong New Area, Shanghai
Shanghai; Shanghai; Postal Code: 201299

Contact Details: Purchase the Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report to view the information.

Website: http://www.medicilon.com.cn

Basic Information
Total Employees:
Purchase the Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report to view the information.
Registered Capital:
Purchase the Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report to view the information.
Incorporation Date:
February 02, 2004
Key Executives
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
14.17%
Purchase this report to view the information.
8.95%
Purchase this report to view the information.
5.92%
Purchase this report to view the information.
4.75%
Purchase this report to view the information.
4.07%
Subsidiaries
MEDICILON USA CORP
100%
Medicilon Biopharmaceutical (Hangzhou) Co., Ltd.
100%
Medicilon Pharmaceutical Technology (Shanghai) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
5.14%▲
Total operating revenue
6.04%▲
Operating profit (EBIT)
74.08%▲
Net Profit (Loss) for the Period
76.93%▲
Total Assets
-5.3%▼
Total Equity
-12.26%▼
Operating Profit Margin (ROS)
15.08%▲
Net Profit Margin
12.53%▲
Return on Equity (ROE)
4.03%▲
Debt/Equity
3.88%▲
Quick Ratio
-0.45%▼
Cash Ratio
0.02%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd.
 
Pulike Biological Engineering,Inc.
Hunan Hansen Pharmaceutical Co., Ltd.
 
Ascentage Pharma Group International (Hong Kong) (亚盛医药集团-B (香港))
Innocare Pharma Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo